Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Plos One|October 12, 2017
Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trialsSteven G Smith, Stephanie A Harris, Iman Satti, et al.
Journal of Bacteriology|April 3, 2012
Important role for Mycobacterium tuberculosis UvrD1 in pathogenesis and persistence apart from its function in nucleotide excision repairJoanna Houghton, Carolin Townsend, Alan R Williams, et al.
The Journal of Biological Chemistry|May 31, 2011
Forkhead-associated (FHA) domain containing ABC transporter Rv1747 is positively regulated by Ser/Thr phosphorylation in Mycobacterium tuberculosisVicky L Spivey, Virginie Molle, Rachael H Whalan, et al.
The Journal of General Virology|August 22, 2001
In situ hybridization and immunolabelling study of the early replication of simian immunodeficiency virus (SIVmacJ5) in vivoCarmen Cantó-Nogués, Sue Jones, Rebecca Sangster, et al.
Infection and Immunity|August 23, 2005
Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in miceEleanor Roy, Evangelos Stavropoulos, John Brennan, et al.
The Review of Scientific Instruments|July 8, 2008
Time-resolved momentum imaging system for molecular dynamics studies using a tabletop ultrafast extreme-ultraviolet light sourceEtienne Gagnon, Arvinder S Sandhu, Ariel Paul, et al.
Virology|November 6, 2004
Vaccination with live attenuated simian immunodeficiency virus for 21 days protects against superinfectionRichard Stebbings, Neil Berry, Jim Stott, et al.
The Journal of Infectious Diseases|February 9, 2012
OX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis infectionRobert J Snelgrove, Megan M Cornere, Lorna Edwards, et al.
Vaccine|May 17, 2005
New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical developmentArun T Kamath, Uli Fruth, Michael J Brennan, et al.
Pageof 4